Vimarsana
Biggest News Aggregation in the World

Biopharma Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biopharma Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biopharma Contract Development Today - Breaking & Trending Today

Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients - Vimarsana News

Eurofins Viracor Launches Ground-Breaking Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients

Eurofins Viracor ExPeCT CAR-T multiplexed quantitative real-time PCR (qPCR) assay provides a powerful diagnostic tool to monitor and optimise CAR-T therapy involving patients with pre-B cell acute

Eurofins Scientific SE: Eurofins Expands Presence in Indian Pharmaceutical Market With New State-of-the-Art Hyderabad Campus - Vimarsana News

Eurofins Scientific SE: Eurofins Expands Presence in Indian Pharmaceutical Market With New State-of-the-Art Hyderabad Campus

Regulatory News: Eurofins Scientific SE (Paris:ERF): Eurofins Scientific (EUFI.PA), the global leader in food, environment, pharmaceutical and cosmetic product testing and a global scientific leader

Eurofins Scientific: Eurofins Successfully Prices New €600m Hybrid Bonds - Vimarsana News

Eurofins Scientific: Eurofins Successfully Prices New €600m Hybrid Bonds

Regulatory News: Eurofins Scientific (EUFI.PA, rated Baa3 by Moody's and BBB- by Fitch, "Eurofins") (Paris:ERF), a global leader in bioanalytical testing, announces that it has successfully raised

Eurofins Launches the Second Tranche of a Buy-back Programme of Its Own Shares - Vimarsana News

Eurofins Launches the Second Tranche of a Buy-back Programme of Its Own Shares

Regulatory News: Eurofins (Paris:ERF): Following the announcement on 3 October 2022 to buy-back some of its own shares (ISIN FR0014000MR3) (the "Share Repurchase Plan") and the completion of the

TRANSPLANT GENOMICS PRESENTS TRUGRAF® LIVER AT THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES - Vimarsana News

TRANSPLANT GENOMICS PRESENTS TRUGRAF® LIVER AT THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

/PRNewswire/ -- Transplant Genomics ("TGI"), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, will be...